UTAH MEDICAL PRODUCTS, INC. (UTMD) Operating cash flow 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$14.7MFY2025 · since FY2016: $14.5M → $14.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.7M | -0.9% |
| FY2024 | $14.8M | -33.4% |
| FY2023 | $22.3M | +5.4% |
| FY2022 | $21.1M | -0.3% |
| FY2021 | $21.2M | +5.3% |
| FY2020 | $20.1M | +18.1% |
| FY2019 | $17.1M | +1.3% |
| FY2018 | $16.8M | -0.4% |
| FY2017 | $16.9M | +16.4% |
| FY2016 | $14.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Gross marginUTMD Operating incomeUTMD Operating marginUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →